ELCC 2024 Insights: "CONVERT Trial - Long-Term Outcomes After Concurrent Once- or Twice-Daily CRT in LS-SCLC" | VuMedi

ecancer

ELCC 2024 Insights: "CONVERT Trial - Long-Term Outcomes After Concurrent Once- or Twice-Daily CRT in LS-SCLC"

By ecancer FEATURING Gerard Walls

By ecancer FEATURING Gerard Walls

55 views

April 23, 2024

0 Comments

Login to view comments. Click here to Login